Rex Bionics Ltd applications

RAPPER II is a multi-centre, international trial to evaluate the feasibility and safety of the REX and of a set of customised exercises performed in a REX; and the impact on quality of life.  56 recruits took part in the study.

The presentation of RAPPER II analysis by Principal Physiotherapy Investigator, Jon Graham BA, MSc, MSCP at the 93rd annual meeting of the American Congress of Rehabilitation Medicine, Chicago Ill, showed that:

REX is used by physiotherapists for people with mobility impairments, in rehabilitation centres in the US, the UK, the Middle East, Australia and New Zealand.

People who have suffered a Traumatic Brain Injury have successfully used a REX. A clinical trial has been conducted by the Australian Institute of Neuro-rehabilitation (AIN), Nelson Bay, New South Wales (NSW), Australia and the University of Newcastle, NSW; and is supported by The Newcastle Permanent Charitable Foundation and Rex Bionics plc.  The trial was open to volunteers from the Hunter Region of NSW, who have had a Stroke or Traumatic Brain Injury more than three months previously and have difficulty standing and walking.  Volunteers were treated twice a week for twelve weeks and the REX treatment was supplemented by a home programme of exercises.   There is provision for MRI examination to correlate the functional and neurological response to treatment.